Ernest F Bizjak
Visit Investigator ProfileInvestigation Details
Detailed Analysis
Ernest F Bizjak adopts a by-the-book approach, meticulously examining compounded drug products, prescriptions, and labeling to ensure strict compliance with FDCA regulations. He prioritizes thorough documentation and evidence of CGMP adherence.
Ernest F Bizjak is a detail-oriented FDA auditor who focuses on compliance with FDCA regulations, particularly in the area of compounded drug products. He emphasizes the need for valid prescriptions for individually-identified patients and is strict about adherence to FDA approval requirements, labeling directions, and CGMP.
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies